|
End-of-day quote
Shanghai S.E.
2026-08-13
|
5-day change | 1st Jan Change | ||
| 17.94 CNY | -1.10% |
|
+0.17% | +1.82% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 4.97% | 5.47% | 13.92x | 2.61x | 0.57x | 4.56x | 7.52x | 3.06B | |
| -.--% | -.--% | 18.18x | 1.6x | 0.77x | 12.14x | 13.03x | 15.79B | |
| 1.01% | 1.25% | 22.21x | 2.5x | 0.87x | 14.6x | 14.88x | 6.85B | |
| 2.29% | 2.62% | 16.32x | 1.73x | 0.74x | 7.69x | 9.67x | 6.21B | |
| 2.82% | 3.11% | 15.01x | 2.28x | 0.98x | 7.1x | 9.29x | 4.32B | |
| 5.84% | 5.87% | 14.99x | 4.65x | 1.28x | 7.83x | 14.65x | 3.33B | |
| 4.42% | 4.85% | 14.5x | 6.56x | 0.87x | 6.58x | 9.15x | 3.05B | |
| 1.95% | 2.37% | 21.03x | 3.68x | 0.61x | 7.81x | 12.79x | 1.57B | |
| 0.02% | -.--% | -107.1x | 2.64x | 0.44x | 16.15x | 69.51x | 1.47B | |
| 3.86% | 4.34% | 13.16x | 0.94x | 0.32x | 3.09x | 6.37x | 1.05B | |
| 6.07% | 5.87% | 13.76x | 2.27x | 0.82x | 6.69x | 14.4x | 872M | |
| 1.39% | 2.01% | 25.78x | 7.03x | 0.93x | 12.73x | 19.73x | 785M | |
| 0.38% | 0.36% | 13.77x | 1.86x | 0.67x | 8.16x | 13.18x | 688M | |
| Average | 2.69% | 2.93% | 7.35x | 3.10x | 0.76x | 8.86x | 16.47x | 3.77B | |
| Weighted average by Cap. | 1.94% | 2.13% | 13.73x | 2.57x | 0.80x | 10.01x | 13.73x |
Select your edition
All financial news and data tailored to specific country editions
